Newsroom

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it has entered into a new accelerated stock repurchase agreement (“ASR”) with Goldman Sachs & Co. LLC (“Goldman Sachs”), to repurchase $270 million of Align’s common s...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Marvell Technology, Inc. (NASDAQ: MRVL), a leader in data infrastructure semiconductor solutions, today announced it will conduct a conference call following the release of its third quarter of fiscal year 2027 financial results on Tuesday, December 1, 2026, at 1:30 p.m. Pacific Time. Conference Call Interested parties may join the live conference call without operator assistance at Call me™ (link will be active approximately 30 minutes before the call) to...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Obsidian Therapeutics, Inc. (Nasdaq: OBX), a clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered tumor-infiltrating lymphocyte (TIL) cell therapies, today announced positive updated results in patients with immune-checkpoint inhibitor (ICI)-resistant advanced melanoma from the Phase 1 single-center first-in-human (FIH) study and the Phase 1/2 Agni-01 multicenter study of amsokigene autoleucel (amsoki-ce...

LARKSPUR, Calif.--(BUSINESS WIRE)--Aulos Bioscience, an immuno-oncology company working to revolutionize cancer care through development of its lead immune-activating antibody therapeutic, imneskibart (AU-007), today announced positive Phase 2 data demonstrating clinical activity with imneskibart-based regimens in heavily pretreated patients with doublet checkpoint inhibitor (CPI)-refractory melanoma and CPI-refractory adenocarcinoma non-small cell lung cancer (NSCLC). The findings, presented i...

明尼阿波利斯--(BUSINESS WIRE)--(美國商業資訊)-- Graco Inc.正透過全球推出3吋QUANTM® i230，協助製造商將高流量流體輸送應用電氣化，把高效電動驅動技術導入以往依賴氣動泵的高要求製程。 塗料、塗層及陶瓷製造商仰賴隔膜泵的彈性、可靠性，以及處理高難度物料的能力。但氣動泵也依賴壓縮空氣——這是一種能耗高的廠內資源，其供應能力會隨廠內各處需求變化而波動。 QUANTM i230為符合條件的高流量應用提供另一種選擇。藉由結合熟悉的隔膜泵功能與電動操作，這款泵浦協助製造商輸送更多物料、減少輸送瓶頸，並相較氣動泵將能耗降低高達80%，同時維持操作彈性。 Graco製程製造事業部銷售總監Jeffrey Shaffer表示：「塗料、塗層及陶瓷等產業的高流量製程，長久以來高度依賴氣動隔膜泵，理由充分——它們彈性佳、可靠，且非常適合處理難以處理的材料。同時，製造商也密切關注能源使用、營運成本，以及如何讓工廠現代化。QUANTM i230為他們提供了另一個選擇。」 製造商可獲得的其他效益包括： 更穩定的效能，無需與廠內空氣系統競爭：在高產量製造中，流體輸送的波動可能影...

SAN FRANCISCO--(BUSINESS WIRE)--Synctera, a leader in embedded finance and banking as a service (BaaS), today announced $24.5M in new funding, bringing total funding to $126.7M. Participants include Multiplier Capital, Fin Capital, 1st & Main Growth Partners, Diagram, and NAventures. The funding backs Synctera's work with sponsor banks and FinTechs as more banks get back in the game with BaaS. "Embedded finance only works when banks can trust what's happening on their charter, and Synctera...

PLANO, Texas--(BUSINESS WIRE)--Diodes Incorporated (Diodes) (Nasdaq: DIOD) today announces the release of the API21550/API21552 series within its RobustISO™ family of isolation products. These dual-channel isolated gate drivers are designed for system engineers who require robust, high-voltage isolation and reliable signal transmission for power-switch driving. Applications include motor drives, solar inverters, battery management systems (BMS), servers, IT and industrial infrastructures, and h...

BENSALEM, Pa.--(BUSINESS WIRE)--Investors who suffered losses on Madrigal Pharmaceuticals, Inc. ("Madrigal" or the "Company") stock may have claims to recover those losses. The Law Offices of Howard G. Smith today reported that it is conducting a securities fraud investigation on behalf of Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) investors into whether the Company may have violated the federal securities laws. The investigation comes after a November 3, 2026 disclosure concerning Madrigal P...

HAYWARD, Calif.--(BUSINESS WIRE)--RefleXion announces CMS maintained premium reimbursement for the third consecutive year, adding to the breakthrough economic value of its X2 platform....

HOUSTON--(BUSINESS WIRE)--Insperity, Inc. (NYSE: NSP), a leading provider of human resources and business performance solutions for America’s best businesses, announced today that Paul Sarvadi, Chairman and Chief Executive Officer, and Jim Allison, Chief Financial Officer, will speak at the J.P. Morgan Ultimate Services Investor Conference on November 17, 2026. The fireside chat presentation is scheduled for 3:20 p.m. Eastern Time. A live audio webcast of the fireside chat presentation will be...